|  | Numbers | No. of Depressive incidents | Model one a | Model two b | Model three c | |||
---|---|---|---|---|---|---|---|---|---|
OR(95%CI) | P-value | OR(95%CI) | P-value | OR(95%CI) | P-value | ||||
Women | Mets (−) | 717 (57.2) | 27 (3.8) | 1.00(reference) | 0.032 | 1.00(reference) | 0.036 | 1.00(reference) | 0.045 |
MetS (+) | 536 (42.8) | 39 (7.3)* | 1.77 (1.05,2.98) | 1.76 (1.04,2.98) | 1.82 (1.01,3.27) | ||||
Elevated WC (−) | 575 (45.9) | 25 (4.3) | 1.00(reference) | 0.306 | 1.00(reference) | 0.338 | 1.00(reference) | 0.42 | |
Elevated WC(+) | 678 (54.1) | 41 (6.0) | 1.31 (0.78,2.19) | 1.29 (0.77,2.17) | 1.31 (0.68,2.50) | ||||
Hypertriglyceridemia (−) | 883 (70.5) | 40 (4.5) | 1.00(reference) | 0.195 | 1.00(reference) | 0.304 | 1.00(reference) | 0.384 | |
Hypertriglyceridemia (+) | 370 (29.5) | 26 (7.0)* | 1.41 (0.84,2.37) | 1.32 (0.78,2.24) | 1.28 (0.74,2.21) | ||||
Low HDL-C (−) | 788 (62.9) | 39 (4.9) | 1.00(reference) | 0.573 | 1.00(reference) | 0.576 | 1.00(reference) | 0.574 | |
Low HDL-C (+) | 465 (37.1) | 27 (5.8) | 1.16 (0.70,1.92) | 1.16 (0.69,1.94) | 1.16 (0.69,1.97) | ||||
Hyperglycemia (−) | 733 (58.5) | 33 (4.5) | 1.00(reference) | 0.343 | 1.00(reference) | 0.383 | 1.00(reference) | 0.458 | |
Hyperglycemia (+) | 520 (41.5) | 33 (6.3) | 1.28 (0.77,2.12) | 1.26 (0.75,2.12) | 1.22 (0.72,2.08) | ||||
Elevated BP (−) | 471 (37.6) | 16 (3.4) | 1.00(reference) | 0.096 | 1.00(reference) | 0.089 | 1.00(reference) | 0.127 | |
Elevated BP (+) | 782 (62.4) | 50 (6.4)* | 1.66 (0.91,3.02) | 1.69 (0.92,3.09) | 1.62 (0.87,3.01) | ||||
Men | Mets (−) | 1021 (66.2) | 26 (2.5) | 1.00(reference) | 0.302 | 1.00(reference) |  | 1.00(reference) |  |
MetS (+) | 522 (33.8) | 18 (3.4) | 1.38 (0.75,2.54) | 1.46 (0.78,2.70) | 0.234 | 1.84 (0.88,3.83) | 0.104 | ||
Elevated WC (−) | 1076 (69.7) | 29 (2.7) | 1.00(reference) | 0.515 | 1.00(reference) | 0.276 | 1.00(reference) | 0.102 | |
Elevated WC(+) | 467 (30.3) | 15 (3.2) | 1.23 (0.65,2.33) | 0.71 (0.38,1.32) | 2.06 (0.87,4.90) | ||||
Hypertriglyceridemia (−) | 1027 (66.6) | 32 (3.2) | 1.00(reference) | 0.428 | 1.00(reference) | 0.421 | 1.00(reference) | 0.392 | |
Hypertriglyceridemia (+) | 516 (33.4) | 12 (2.3) | 0.76 (0.39,1.49) | 0.76 (0.38,1.49) | 0.73(.35,1.51) | ||||
Low HDL-C (−) | 1310 (84.9) | 36 (2.7) | 1.00(reference) | 0.503 | 1.00(reference) | 0.545 | 1.00(reference) | 0.436 | |
Low HDL-C (+) | 233 (15.1) | 8 (3.4) | 1.31 (0.60,2.86) | 1.28 (0.58,2.84) | 1.39 (0.61,3.20) | ||||
Hyperglycemia (−) | 750 (48.6) | 25 (3.3) | 1.00(reference) | 0.231 | 1.00(reference) | 0.402 | 1.00(reference) | 0.307 | |
Hyperglycemia (+) | 793 (51.4) | 19 (2.4) | 0.69 (0.38,1.27) | 1.32 (0.69,2.52) | 0.72 (0.39,1.35) | ||||
Elevated BP (−) | 386 (25.0) | 11 (2.8) | 1.00(reference) | 0.812 | 1.00(reference) | 0.897 | 1.00(reference) | 0.826 | |
Elevated BP (+) | 1157 (75.0) | 33 (2.9) | 0.92 (0.45,1.86) | 0.95 (0.47,1.96) | 0.92 (0.44,1.94) |